Article
Analysis of mutant p53 and telomerase activity in non-small cell lung cancer.
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia - 1 Oct 1999
Kiyooka K, Maniwa Y, Okada M
Abstract excerpt
The number of mutant p53 protein-positive tumor cells in primary non-small cell lung carcinoma (NSCLC) cases were quantitated by flow cytometry (FCM) and the relationships of these data to various factors were evaluated. Furthermore, the method of quantitating telomerase activity was investigated. Forty patients with primary lung carcinoma encountered between December 1995 and December 1997 were investigated....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.